New eye drop BUFY01 takes on SVS20 in dry eye showdown

NCT ID NCT05865379

Recruiting now Symptom relief Sponsor: TRB Chemedica International SA Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 2 times

Summary

This study tests whether a new eye drop, BUFY01, works as well as an existing one, SVS20, for people with dry eye disease. About 80 participants will use one of the two drops daily for three months. Researchers will check eye health and ask about symptoms to see if the treatments are similarly effective and safe.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRY EYE DISEASE

Contacts and locations

Locations

CHU Saint-Etienne
RECRUITING

Saint-Priest-en-Jarez, France
Hôpital des Quinze-Vingts
RECRUITING

Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.